Sims, Steven
Barak, Orly
Ryu, Vitaly
Miyashita, Sari
Kannangara, Hasni
Korkmaz, Funda
Wizman, Soleil http://orcid.org/0009-0004-5149-5645
Macdonald, Anne
Gumerova, Anisa
Goosens, Ki http://orcid.org/0000-0002-5246-2261
Zaidi, Mone http://orcid.org/0000-0001-5911-9522
Yuen, Tony
Lizneva, Daria
Frolinger, Tal
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG071870, R01AG074092, U01AG073148, U19AG060917, R01AG071870, R01AG074092, U01AG073148)
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
Article History
Received: 4 March 2023
Revised: 25 July 2023
Accepted: 27 July 2023
First Online: 10 August 2023
Competing interests
: MZ is inventor on issued and pending patients on the use of FSH as a target for osteoporosis, obesity and Alzheimer’s disease. MZ, TY and DL are inventors on a submitted patent application relating to the role of LH in regulating body composition. The patents will be held by Icahn School of Medicine at Mount Sinai, and MZ, TY and/or DL would be recipient of royalties, <i>per</i> institutional policy. The other authors declare no competing financial interests.